Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis.

Josep GamezAlejandro GamezFrancesc Carmona

Published in: Muscle & nerve (2022)

Our data are consistent with the mRNA COVID-19 vaccine being well tolerated in patients with well-controlled MG. The findings may contribute to decisions in vaccination campaigns in the future.

Keyphrases

coronavirus disease
myasthenia gravis
sars cov

binding protein
respiratory syndrome coronavirus

current status
big data

machine learning
artificial intelligence